Shytoshi Kusama’s “biggest announcement” triggers the Shibiba Inu ecosystem rally in ecosystem tokens

Shytoshi Kusamathe main ambassador of Shiba Inu SHIB / USD Fraternity, said on Monday that he was preparing to make the “biggest announcement” ever linked to the blockchain ecosystem.

What happened: Kusama went to X to tease the important event, declaring: “After a few rest, I will focus on Shib. Bone, leave and treatment while we are preparing for the biggest announcement that I have ever given. »»

The declaration comes after the mysterious personality described a roadmap to help support the growth of SHYA consumption token supported by the community inspired by itself. Kusama added that the “robust” approach will allow the project to compete with HasbroA renowned toy and game company.

A consumer token offer, or CTO, is a fundraising mechanism in which an entity directly sells cryptocurrencies to customers, granting them access to specific products or services within the blockchain ecosystem.

Interesting, the Solara SOL / USD -The tokens based on 72% in the last 24 hours, according to at Dex Screaminer. To date, it has accumulated a market capitalization of $ 6 million.

See also:: Robert Kiyosaki predicts another stock market crash, says Bitcoin Investments – Here is what the author of the “Rich Dad Poor Dad” says

Why it matters: Kusama’s remarks came shortly after his transition From Shiba Inu Lead Visionary to the role of main ambassador. He said that the Shiba Inu project now requires more execution and communication rather than vision.

The community was overflowing from the launch of its latest token, Shiba Inu Treat (TO TREAT), A piece of meme utility This provides awards, governance and liquidity.

Treat is the last addition to the Shiba Inu token arsenal which includes Shib, the popular cryptocurrency on the theme of dogs, Killer (Leave), and Bone shibaswap OS / USD.

Action: At the time of the editorial staff of the moment, Shib exchanged hands at $ 0,0000,191, up 7.26% in the past 24 hours, according to Benzinga Pro data. The treatment was raised by 24.39%, while the bones increased by 5.13%.

Read then:

Non-liability clause: This content was partially produced with the help of Benzinga Neuro and was examined and published by the publishers of Benzinga.